 "Cairn India, Biocon, Nestle India, Dalmia Bharat, Grasim hit 52-week high")
Biocon, Bharat Financial Inclusion, Motilal Oswal Financial Services and Lakshmi Vilas Bank are among 31 stocks from the S&P BSE 500 & S&P BSE Allcap index hitting their respective 52-week highs after reporting robust earnings for the first quarter ended June 30, 2016 (Q1FY17).
Cairn India, Nestle India, Grasim Industries, Dalmia Bharat, Bajaj Finance, Finolex Cables, GHCL, Godrej Industries, Repco Home Finance, Tube Investments of India and Finolex Cables are others from the list too touched 52-week highs on Friday.
Motilal Oswal Financial Services has surged 20% to Rs 504 after reported a nearly three-fold jump in net profit at Rs 79 crore in Q1FY17, against Rs 28 crore in the same quarter last fiscal. Revenues surged 69% to Rs 351 crore during the quarter under review.
"While we have increased our business volumes, asset mobilisation and client addition, we also improved our market share in some of our businesses," the firm's Chairman and Managing Director Motilal Oswal said in a statement.
"This trend is expected to continue... Strong liquidity on balance sheet allows us to fund investments in new initiatives including housing finance, private equity, etc," he added.
Bharat Financial Services (formerly SKS Microfinance) rallied 17% to Rs 891 after the company reported nearly four-fold jump in net profit at Rs 236 crore in Q1FY17. The microfinance company had profit of Rs 61 crore in the year ago quarter.
The company said its weighted average cost of borrowing reduced to 10.7% in Q1-FY17 from 11.1% in Q4-FY16 and 11.9% in Q1-FY16.
Biocon soared 15% to Rs 804 after the biopharma company reported 35% year-on-year (YoY) jump in its consolidated net profit of Rs 167 crore in Q1FY17.
In separate filing, Biocon said the European Medicines Agency (EMA)—the European Union (EU) drug regulator—has accepted for review, Mylan NV’s marketing authorization application for the proposed biosimilar pegfilgrastim, used to stimulate the level of neutrophils, a type of white blood cells in cancer patients undergoing chemotherapy. Biocon has a partnership with Mylan to co-develop specific biosimilars.
Cairn India up nearly 6% to Rs 187 after the company reported consolidated net profit of Rs 360 crore in Q1FY16. The company had posted net loss of Rs 506 crore in March 2016 quarter. Net revenue increased by 10% at Rs 1,885 crore sequentially on account of a significant rise in Brent prices.
Cairn India, Nestle India, Grasim Industries, Dalmia Bharat, Bajaj Finance, Finolex Cables, GHCL, Godrej Industries, Repco Home Finance, Tube Investments of India and Finolex Cables are others from the list too touched 52-week highs on Friday.
Motilal Oswal Financial Services has surged 20% to Rs 504 after reported a nearly three-fold jump in net profit at Rs 79 crore in Q1FY17, against Rs 28 crore in the same quarter last fiscal. Revenues surged 69% to Rs 351 crore during the quarter under review.
"While we have increased our business volumes, asset mobilisation and client addition, we also improved our market share in some of our businesses," the firm's Chairman and Managing Director Motilal Oswal said in a statement.
"This trend is expected to continue... Strong liquidity on balance sheet allows us to fund investments in new initiatives including housing finance, private equity, etc," he added.
Bharat Financial Services (formerly SKS Microfinance) rallied 17% to Rs 891 after the company reported nearly four-fold jump in net profit at Rs 236 crore in Q1FY17. The microfinance company had profit of Rs 61 crore in the year ago quarter.
The company said its weighted average cost of borrowing reduced to 10.7% in Q1-FY17 from 11.1% in Q4-FY16 and 11.9% in Q1-FY16.
Biocon soared 15% to Rs 804 after the biopharma company reported 35% year-on-year (YoY) jump in its consolidated net profit of Rs 167 crore in Q1FY17.
In separate filing, Biocon said the European Medicines Agency (EMA)—the European Union (EU) drug regulator—has accepted for review, Mylan NV’s marketing authorization application for the proposed biosimilar pegfilgrastim, used to stimulate the level of neutrophils, a type of white blood cells in cancer patients undergoing chemotherapy. Biocon has a partnership with Mylan to co-develop specific biosimilars.
Cairn India up nearly 6% to Rs 187 after the company reported consolidated net profit of Rs 360 crore in Q1FY16. The company had posted net loss of Rs 506 crore in March 2016 quarter. Net revenue increased by 10% at Rs 1,885 crore sequentially on account of a significant rise in Brent prices.
| COMPANY | LATEST | 52 WK HIGH | PREV HIGH | PREV DATE |
| ADITYA BIR. NUV. | 1352.20 | 1377.00 | 1347.80 | 21-Jul-16 |
| ALKEM LAB | 1575.35 | 1590.00 | 1589.00 | 05-Jan-16 |
| ATUL | 2200.00 | 2222.00 | 2193.00 | 21-Jul-16 |
| BAJAJ FIN. | 8789.10 | 8864.95 | 8835.00 | 18-Jul-16 |
| BAJAJ HOLDINGS | 1770.00 | 1790.00 | 1745.00 | 18-Dec-15 |
| BANCO PRODUCTS | 168.90 | 172.00 | 166.80 | 21-Jul-16 |
| BHARAT FINANCIAL | 844.00 | 844.00 | 799.70 | 20-Jul-16 |
| BIOCON | 792.65 | 798.95 | 766.00 | 30-Jun-16 |
| CAIRN INDIA | 185.10 | 186.60 | 184.20 | 23-Jul-15 |
| CAPITAL FIRST | 682.50 | 694.00 | 686.30 | 20-Jul-16 |
| DALMIA BHAR. | 1440.00 | 1451.50 | 1359.00 | 21-Jul-16 |
| EDELWEISS.FIN. | 86.90 | 88.50 | 85.40 | 21-Jul-16 |
| FINOLEX CABLES | 391.00 | 394.80 | 384.80 | 21-Jul-16 |
| GABRIEL INDIA | 104.25 | 105.40 | 105.25 | 18-Jul-16 |
| GHCL | 201.00 | 202.70 | 201.05 | 12-Jul-16 |
| GODREJ INDS. | 437.00 | 437.45 | 434.30 | 21-Jul-16 |
| GRASIM INDS | 4910.95 | 4953.65 | 4929.00 | 21-Jul-16 |
| GUJ ALKALIES | 243.10 | 248.90 | 236.10 | 30-Jun-16 |
| IFGL REFRACTOR | 140.40 | 144.00 | 144.00 | 20-Jul-16 |
| IIFL HOLDINGS | 254.90 | 266.40 | 248.80 | 21-Jul-16 |
| JM FINANCIAL | 62.40 | 63.00 | 59.15 | 21-Jul-16 |
| LAK. VILAS BANK | 123.95 | 124.50 | 121.90 | 21-Jul-16 |
| MOTIL.OSWAL.FIN. | 500.25 | 503.80 | 446.00 | 13-Jul-16 |
| NESTLE INDIA | 7000.00 | 7044.00 | 7000.00 | 05-Aug-15 |
| PRICOL | 103.70 | 106.10 | 101.75 | 18-Jul-16 |
| REPCO HOME FIN | 848.10 | 870.45 | 840.00 | 21-Jul-16 |
| SHREE CEMENT | 16350.00 | 16474.65 | 16450.00 | 21-Jul-16 |
| TATA METALIKS | 459.00 | 512.90 | 504.95 | 21-Jul-16 |
| TUBE INVESTMENTS | 534.00 | 536.35 | 535.45 | 21-Jul-16 |
| VARDHMAN TEXTILE | 1072.00 | 1075.00 | 1075.00 | 21-Jul-16 |
| VST TILL. TRACT. | 2004.30 | 2035.00 | 2030.00 | 20-Jul-16 |
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%